Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315380 · ClinicalTrials.gov registry record
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
A clinical trial of Eosinophilic Granulomatosis With Polyangiitis and Churg-Strauss Syndrome, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 700
- Enrollment target
- 13
- Study locations
NCT00315380: Recruiting study of Eosinophilic Granulomatosis With Polyangiitis and Churg-Strauss Syndrome, sponsored by University of Pennsylvania.
NCT00315380 is a study of Eosinophilic Granulomatosis With Polyangiitis and Churg-Strauss Syndrome that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 700 participants, above the 403-participant average among 3 other Eosinophilic Granulomatosis With Polyangiitis trials with a reported enrollment target (74% higher). The trial reports 13 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00315380, a study of Eosinophilic Granulomatosis With Polyangiitis and Churg-Strauss Syndrome, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 13
- Study locations
Study Summary
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.
Conditions Studied
Study Locations (13)
Other
- medius KLINIK KIRCHHEIM - Kirchheim unter Teck
- AOU Meyer IRCCS - Florence
- Imperial College Healthcare NHS Trust/ Imperial College London - London
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Ontario
- St. Joseph's Healthcare - Hamilton
- Mount Sinai Hospital - Toronto
California
- University of California San Diego - San Diego
Colorado
- National Jewish Health - Denver
Massachusetts
- Brigham and Women's Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2006-04 |
| Est. Completion | 2028-12 |
What NCT00315380 shows while recruiting
NCT00315380 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, above the 403-participant average among 3 other Eosinophilic Granulomatosis With Polyangiitis trials with a reported enrollment target (74% higher).
The record links to 2 conditions, with Eosinophilic Granulomatosis With Polyangiitis appearing as the primary indexed condition, and to 0 interventions.
NCT00315380 lists 13 locations in 9 states (Other, Pennsylvania, Ontario).
Frequently Asked Questions
What is clinical trial NCT00315380 about?
NCT00315380 is a clinical study titled "Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis". Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level...
What is the current status of trial NCT00315380?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2006-04. Estimated completion is 2028-12.
What conditions does trial NCT00315380 study?
This clinical trial studies the following conditions: Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome.
Who is sponsoring clinical trial NCT00315380?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00315380 being conducted?
This trial has 13 study locations across California, Colorado, Massachusetts, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Granulomatosis With Polyangiitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
RECRUITING · Phase 2
-
VCRC Tissue Repository
RECRUITING
-
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia